Addressing Coronary Artery Disease Pre- and Post-TAVR
Presenter
John C. Messenger, M.D., MSCAI, University of Colorado Anschutz Medical Campus, Denver, CO
John C. Messenger, M.D., MSCAI, University of Colorado Anschutz Medical Campus, Denver, CO
Learning Objectives:
- Discuss the timing and strategies for managing CAD in patients scheduled for TAVR, including the physiologic assessment of disease, considerations for staging PCI and the impact of CAD severity on outcomes.
- Understand the importance of coronary and commissural alignment during TAVR to ensure optimal future coronary access.
- Review best practices for evaluating and managing CAD after TAVR, including navigating the challenges posed by transcatheter valve struts and commissures.
Keywords: Structural Heart Disease (SHD)